Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Roche pipeline takes stage

Wednesday, March 17th, 2010

Top executives with the Swiss pharma giant, eager to shift attention from a series of recent clinical-trial setbacks, will be in New York City tomorrow for the company's first investor conference since its buyout of Genentech. They are expected to emphasize the potential created by Roche's new biotech arm and highlight several promising pipeline drugs, led by Phase III blockbuster candidates dalcetrapib, aleglitazar, and RG1678.  I will be on ...

Posted in Uncategorized, clinical trials | No Comments »

Acceleron looks past VEGF in cancer treatment

Friday, November 6th, 2009

Many cancer treatments being developed in the clinic focus on the VEGF pathway by blocking multiple kinase inhibitors or different proliferative agents simultaneously, which usually leads to serious side effects. But VEGF is just one piece of the tumor angiogenesis puzzle. Executives with Acceleron Pharma Inc. believe that a need exists ...

Posted in cancer, clinical trials | 1 Comment »

   
about us | advertise | contact us | home
terms of use | privacy | copyright | site map 		©2012 UBM Canon